GLOBEALERT
HEALTHLOWJul 17 · Jul 17, 2026, 1:30 AM

Telix Completes Patient Enrollment in TLX591 - Px ( Illuccix ) Japan Phase 3 Study

vietnamtribune.com · Vietnam

Telix has completed patient enrollment for its TLX591-Px (Illuccix) Phase 3 study in Japan. This marks a milestone in the development of a new medical treatment.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More from Vietnam

More in Health